Market Research Logo

HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assay], Molecular Assays [PCR based molecular assays, Sequencing based molecular assays {Sanger Sequencing, Next Generation Sequencing}

HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assay], Molecular Assays [PCR based molecular assays, Sequencing based molecular assays {Sanger Sequencing, Next Generation Sequencing}]), By Product and Services (Instruments, Reagents and Consumables, Software, Services), By Application (Diagnostics, Research), By End-Use (Hospitals, Academic and Research Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

HLA Typing for Transplant Market will exceed USD 0.8 billion by 2025; as per a new research report.

Increasing number of soft tissue, stem cells, and solid organ transplantations coupled with technological advancements in HLA typing are the foremost driving factors for HLA typing for transplant business growth over the forecast timeframe. In addition, increasing number of solid organ transplants, technological advancements and growing geriatric population will boost the global HLA typing for transplant market growth. Asia Pacific will experience lucrative growth opportunities in the coming years mainly due to high presence of unmet organ needs with infrastructural development and burgeoning disposable income in the developing economies of the region.

There has been a paradigm shift in the solid organ transplantation technique from experimental procedure to necessary and lifesaving surgery. According to the U.S department of Health and Human Services, 92 transplants occur in U.S. each day. Similarly, 31,839 organ transplants have been performed in U.S. from January- November 2017. As HLA testing techniques are used to match organ transplant recipients with compatible donors, the increase in transplants would eventually fuel the growth of market.

Molecular assays market held the majority of market share in the year 2018 and was valued at USD 319.7 million. Growth in the molecular assay segment is attributed to rising end-user preference for affordable and efficient DNA sequencing technologies, the continuously increasing demand for high-throughput DNA sequencers in HLA typing, expansion in application horizons of NGS in tissue typing, and increasing usage of NGS systems among researchers and diagnostic laboratories.

Reagents and consumables market is estimated to witness a considerable amount of growth at a CAGR of 11.4% during the projection period. High demand for reagents and consumables accompanied by significant price and high margin in kits are one of the reason for elevated market share of the segment. Volume sales also has a positive effect on the revenue generated by reagents and consumables segment, thereby enhancing the segment growth.

Diagnostics market held the major market share and was valued at around USD 308.3 million in the year 2018. Increasing incidence and prevalence of chronic diseases leading to need for organ transplant will boost the market for diagnostics application. Kidney transplant is the most common organ transplant done globally. Increasing awareness activities for organ donations by public, private institutions and NGOs is likely to improve current demand for HLA typing diagnostic application.

The hospitals segment is projected to grow at a robust CAGR of 11.2% over the forecast timeframe. Hospitals are responsible to conduct most of the diagnostics tests required HLA typing for organ transplant and thus accounted for maximum market share in 2018. Furthermore, rising number of patient visit and growing number of transplant procedures that occurs mostly in hospitals will increase demand for HLA typing in the coming year.

U.S. dominated the North America HLA typing for transplant market and was valued at around USD 133.5 million in the year 2018. Growth in U.S. is primarily supported by the strongly increasing number of organ transplantations. The country has witnessed around 20 percent of increase in number of organ transplantations from 2012 to end of the 2017 which accounts for 33,600 transplantations in the year 2016. Asia Pacific will grow at significant rate as a result of growing hematopoietic transplantation, increasing number of bone marrow donors. Additionally, rising awareness about cord banking and organ transplantation will boost Asia Pacific business growth.

The major industry players in the HLA typing for transplant market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina Inc. and Bio-Rad Laboratories. These companies mainly focus on the strategies such as merger, acquisition, new product development and new product launches in order to enhance their product portfolio and strengthen the market position.


Chapter 1 Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2 Executive Summary
2.1 HLA typing for transplant industry 360 degree synopsis, 2014 - 2025
2.1.1 Business trends
2.1.2 Technology trends
2.1.3 Product and services trends
2.1.4 Application trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 HLA Typing for Transplant Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2014- 2025
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of solid organ transplants
3.3.1.2 Technological advancements
3.3.1.3 Increasing geriatric population
3.3.2 Industry pitfalls and challenges
3.3.2.1 Significant gap between number of organs donated and organs required
3.3.2.2 High costs of molecular tests
3.4 Growth potential analysis
3.4.1 By technology
3.4.2 By product and services
3.4.3 By application
3.4.4 By end-use
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter's analysis
3.7 Competitive landscape, 2018
3.7.1 Strategic dashboard
3.8 PESTEL analysis
Chapter 4 HLA Typing for Transplant Market, By Technology
4.1 Key segment trends
4.2 Non-Molecular assays
4.2.1 Market estimates and forecast, by region, 2014 - 2025
4.2.2 Serological assays
4.2.2.1 Market estimates and forecast, by region, 2014 - 2025
4.2.3 Mixed lymphocyte culture assay
4.2.3.1 Market estimates and forecast, by region, 2014 - 2025
4.3 Molecular assays
4.3.1 Market estimates and forecast, by region, 2014 - 2025
4.3.2 PCR based molecular assays
4.3.2.1 Market estimates and forecast, by region, 2014 - 2025
4.3.3 Sequencing based molecular assays
4.3.3.1 Market estimates and forecast, by region, 2014 - 2025
4.3.3.2 Sanger sequencing
4.3.3.2.1 Market estimates and forecast, by region, 2014 - 2025
4.3.3.3 Next generation sequencing
4.3.3.3.1 Market estimates and forecast, by region, 2014 - 2025
Chapter 5 HLA Typing for Transplant Market, By Product and Services
5.1 Key segment trends
5.2 Instruments
5.2.1 Market estimates and forecast, by region, 2014 - 2025
5.3 Reagents and consumables
5.3.1 Market estimates and forecast, by region, 2014 - 2025
5.4 Software
5.4.1 Market estimates and forecast, by region, 2014 - 2025
5.5 Services
5.5.1 Market estimates and forecast, by region, 2014 - 2025
Chapter 6 HLA Typing for Transplant Market, By Application
6.1 Key segment trends
6.2 Diagnostics
6.2.1 Market size by region, 2014 - 2025
6.3 Research
6.3.1 Market size by region, 2014 - 2025
Chapter 7 HLA Typing for Transplant Market, By End-Use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market estimates and forecast, by region, 2014 - 2025
7.3 Academic and research institutes
7.3.1 Market estimates and forecast, by region, 2014 - 2025
Chapter 8 HLA typing for transplant Market, By Region
8.1 Key segment trends
8.2 North America
8.2.1 Market size, by country, 2014 - 2025
8.2.2 Market size, by technology, 2014 - 2025
8.2.2.1 Market size, by non-molecular, 2014 - 2025
8.2.2.2 Market size, by molecular Assays, 2014 - 2025
8.2.2.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.2.3 Market size, by product and services, 2014 - 2025
8.2.4 Market size, by application, 2014 - 2025
8.2.5 Market size, by end-use, 2014 - 2025
8.2.6 U.S.
8.2.6.1 Market size, by technology, 2014 - 2025
8.2.6.1.1 Market size, by non-molecular, 2014 - 2025
8.2.6.1.2 Market size, by molecular assays, 2014 - 2025
8.2.6.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.2.6.2 Market size, by product and services, 2014 - 2025
8.2.6.3 Market size, by application, 2014 - 2025
8.2.6.4 Market size, by end-use, 2014 - 2025
8.2.7 Canada
8.2.7.1 Market size, by technology, 2014 - 2025
8.2.7.1.1 Market size, by non-molecular, 2014 - 2025
8.2.7.1.2 Market size, by molecular assays, 2014 - 2025
8.2.7.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.2.7.2 Market size, by product and services, 2014 - 2025
8.2.7.3 Market size, by application, 2014 - 2025
8.2.7.4 Market size, by end-use, 2014 - 2025
8.3 Europe
8.3.1 Market size, by country, 2014 - 2025
8.3.2 Market size, by technology, 2014 - 2025
8.3.2.1 Market size, by non-molecular, 2014 - 2025
8.3.2.2 Market size, by molecular assays, 2014 - 2025
8.3.2.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.3.3 Market size, by product and services, 2014 - 2025
8.3.4 Market size, by application, 2014 - 2025
8.3.5 Market size, by end-use, 2014 - 2025
8.3.6 Germany
8.3.6.1 Market size, by technology, 2014 - 2025
8.3.6.1.1 Market size, by non-molecular, 2014 - 2025
8.3.6.1.2 Market size, by molecular assays, 2014 - 2025
8.3.6.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.3.6.2 Market size, by product and services, 2014 - 2025
8.3.6.3 Market size, by application, 2014 - 2025
8.3.6.4 Market size, by end-use, 2014 - 2025
8.3.7 UK
8.3.7.1 Market size, by technology, 2014 - 2025
8.3.7.1.1 Market size, by non-molecular, 2014 - 2025
8.3.7.1.2 Market size, by molecular assays, 2014 - 2025
8.3.7.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.3.7.2 Market size, by product and services, 2014 - 2025
8.3.7.3 Market size, by application, 2014 - 2025
8.3.7.4 Market size, by end-use, 2014 - 2025
8.3.8 France
8.3.8.1 Market size, by technology, 2014 - 2025
8.3.8.1.1 Market size, by non-molecular, 2014 - 2025
8.3.8.1.2 Market size, by molecular assays, 2014 - 2025
8.3.8.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.3.8.2 Market size, by product and services, 2014 - 2025
8.3.8.3 Market size, by application, 2014 - 2025
8.3.8.4 Market size, by end-use, 2014 - 2025
8.3.9 Italy
8.3.9.1 Market size, by technology, 2014 - 2025
8.3.9.1.1 Market size, by non-molecular, 2014 - 2025
8.3.9.1.2 Market size, by molecular assays, 2014 - 2025
8.3.9.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.3.9.2 Market size, by product and services, 2014 - 2025
8.3.9.3 Market size, by application, 2014 - 2025
8.3.9.4 Market size, by end-use, 2014 - 2025
8.3.10 Spain
8.3.10.1 Market size, by technology, 2014 - 2025
8.3.10.1.1 Market size, by non-molecular, 2014 - 2025
8.3.10.1.2 Market size, by molecular assays, 2014 - 2025
8.3.10.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.3.10.2 Market size, by product and services, 2014 - 2025
8.3.10.3 Market size, by application, 2014 - 2025
8.3.10.4 Market size, by end-use, 2014 - 2025
8.3.11 Russia
8.3.11.1 Market size, by technology, 2014 - 2025
8.3.11.1.1 Market size, by non-molecular, 2014 - 2025
8.3.11.1.2 Market size, by molecular assays, 2014 - 2025
8.3.11.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.3.11.2 Market size, by product and services, 2014 - 2025
8.3.11.3 Market size, by application, 2014 - 2025
8.3.11.4 Market size, by end-use, 2014 - 2025
8.4 Asia Pacific
8.4.1 Market size, by country, 2014 - 2025
8.4.2 Market size, by technology, 2014 - 2025
8.4.2.1 Market size, by non-molecular, 2014 - 2025
8.4.2.2 Market size, by molecular assays, 2014 - 2025
8.4.2.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.4.3 Market size, by product and services, 2014 - 2025
8.4.4 Market size, by application, 2014 - 2025
8.4.5 Market size, by end-use, 2014 - 2025
8.4.6 China
8.4.6.1 Market size, by technology, 2014 - 2025
8.4.6.1.1 Market size, by non-molecular, 2014 - 2025
8.4.6.1.2 Market size, by molecular assays, 2014 - 2025
8.4.6.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.4.6.2 Market size, by product and services, 2014 - 2025
8.4.6.3 Market size, by application, 2014 - 2025
8.4.6.4 Market size, by end-use, 2014 - 2025
8.4.7 India
8.4.7.1 Market size, by technology, 2014 - 2025
8.4.7.1.1 Market size, by non-molecular, 2014 - 2025
8.4.7.1.2 Market size, by molecular assays, 2014 - 2025
8.4.7.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.4.7.2 Market size, by product and services, 2014 - 2025
8.4.7.3 Market size, by application, 2014 - 2025
8.4.7.4 Market size, by end-use, 2014 - 2025
8.4.8 Japan
8.4.8.1 Market size, by technology, 2014 - 2025
8.4.8.1.1 Market size, by non-molecular, 2014 - 2025
8.4.8.1.2 Market size, by molecular assays, 2014 - 2025
8.4.8.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.4.8.2 Market size, by product and services, 2014 - 2025
8.4.8.3 Market size, by application, 2014 - 2025
8.4.8.4 Market size, by end-use, 2014 - 2025
8.4.9 Australia
8.4.9.1 Market size, by technology, 2014 - 2025
8.4.9.1.1 Market size, by non-molecular, 2014 - 2025
8.4.9.1.2 Market size, by molecular assays, 2014 - 2025
8.4.9.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.4.9.2 Market size, by product and services, 2014 - 2025
8.4.9.3 Market size, by application, 2014 - 2025
8.4.9.4 Market size, by end-use, 2014 - 2025
8.5 Latin America
8.5.1 Market size, by country, 2014 - 2025
8.5.2 Market size, by technology, 2014 - 2025
8.5.2.1 Market size, by non-molecular, 2014 - 2025
8.5.2.2 Market size, by molecular assays, 2014 - 2025
8.5.2.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.5.3 Market size, by product and services, 2014 - 2025
8.5.4 Market size, by application, 2014 - 2025
8.5.5 Market size, by end-use, 2014 - 2025
8.5.6 Brazil 119
8.5.6.1 Market size, by technology, 2014 - 2025
8.5.6.1.1 Market size, by non-molecular, 2014 - 2025
8.5.6.1.2 Market size, by molecular assays, 2014 - 2025
8.5.6.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.5.6.2 Market size, by product and services, 2014 - 2025
8.5.6.3 Market size, by application, 2014 - 2025
8.5.6.4 Market size, by end-use, 2014 - 2025
8.5.7 Mexico
8.5.7.1 Market size, by technology, 2014 - 2025
8.5.7.1.1 Market size, by non-molecular, 2014 - 2025
8.5.7.1.2 Market size, by molecular assays, 2014 - 2025
8.5.7.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.5.7.2 Market size, by product and services, 2014 - 2025
8.5.7.3 Market size, by application, 2014 - 2025
8.5.7.4 Market size, by end-use, 2014 - 2025
8.6 MEA
8.6.1 Market size, by country, 2014 - 2025
8.6.2 Market size, by technology, 2014 - 2025
8.6.2.1 Market size, by non-molecular, 2014 - 2025
8.6.2.2 Market size, by molecular assays, 2014 - 2025
8.6.2.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.6.3 Market size, by product and services, 2014 - 2025
8.6.4 Market size, by application, 2014 - 2025
8.6.5 Market size, by end-use, 2014 - 2025
8.6.6 South Africa
8.6.6.1 Market size, by technology, 2014 - 2025
8.6.6.1.1 Market size, by non-molecular, 2014 - 2025
8.6.6.1.2 Market size, by molecular assays, 2014 - 2025
8.6.6.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.6.6.2 Market size, by product and services, 2014 - 2025
8.6.6.3 Market size, by application, 2014 - 2025
8.6.6.4 Market size, by end-use, 2014 - 2025
8.6.7 Saudi Arabia
8.6.7.1 Market size, by technology, 2014 - 2025
8.6.7.1.1 Market size, by non-molecular, 2014 - 2025
8.6.7.1.2 Market size, by molecular assays, 2014 - 2025
8.6.7.1.2.1 Market size, sequencing based molecular assays, 2014 - 2025
8.6.7.2 Market size, by product and services, 2014 - 2025
8.6.7.3 Market size, by application, 2014 - 2025
8.6.7.4 Market size, by end-use, 2014 - 2025
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Product landscape
9.1.4 Strategic outlook
9.1.5 SWOT analysis
9.2 Bio-Rad Laboratories
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Bio-Reference Laboratories
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 CareDx, Inc.
9.4.1 Business overview
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 F. Hoffmann-La Roche Ltd.
9.5.1 Business overview
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 GenDx
9.6.1 Business overview
9.6.2 Product landscape
9.6.3 Strategic outlook
9.6.4 SWOT analysis
9.7 Illumina Inc.
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Immucor Inc.
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Inno-train Diagnostik GmbH
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 SWOT analysis
9.10 Luminex Corporation
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 SWOT analysis
9.11 Omixon Inc.
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 Pacific Biosciences of California, Inc.
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 SWOT analysis
9.13 Qiagen
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Product landscape
9.13.4 Strategic outlook
9.13.5 SWOT analysis
9.14 Thermo Fischer Scientific (Linkage Biosciences)
9.14.1 Business overview
9.14.2 Financial data
9.14.3 Product landscape
9.14.4 Strategic outlook
9.14.5 SWOT analysis
Data Tables
TABLE 1. HLA typing for transplant industry 360 degree synopsis, 2014 - 2025
TABLE 2. Global HLA typing for transplant market, 2014-2025 (USD Million)
TABLE 3. Global HLA typing for transplant market, by technology, 2014-2025 (USD Million)
TABLE 4. Global HLA typing for transplant market, by product and services, 2014-2025 (USD Million)
TABLE 5. Global HLA typing for transplant market, by application, 2014-2025 (USD Million)
TABLE 6. Global HLA typing for transplant market, by end-use, 2014-2025 (USD Million)
TABLE 7. Global HLA typing for transplant market, by region, 2014-2025 (USD Million)
TABLE 8. Non-Molecular assays market, by region, 2014 - 2025 (USD Million)
TABLE 9. Serological assays market, by region, 2014 - 2025 (USD Million)
TABLE 10. Mixed lymphocyte culture assay market, by region, 2014 - 2025 (USD Million)
TABLE 11. Molecular assays market, by region, 2014 - 2025 (USD Million)
TABLE 12. PCR based molecular assays market, by region, 2014 - 2025 (USD Million)
TABLE 13. Sequencing based molecular assays market, by region, 2014 - 2025 (USD Million)
TABLE 14. Sanger Sequencing market, by region, 2014 - 2025 (USD Million)
TABLE 15. Next generation sequencing market, by region, 2014 - 2025 (USD Million)
TABLE 16. Instruments market, by region, 2014 - 2025 (USD Million)
TABLE 17. Reagents and consumables market, by region, 2014 - 2025 (USD Million)
TABLE 18. Software market, by region, 2014 - 2025 (USD Million)
TABLE 19. Services market, by region, 2014 - 2025 (USD Million)
TABLE 20. Diagnostics market by region, 2014 - 2025 (USD Million)
TABLE 21. Research market by region, 2014 - 2025 (USD Million)
TABLE 22. Hospitals market, by region, 2014-2025 (USD Million)
TABLE 23. Academic and research institutes market, by region, 2014-2025 (USD Million)
TABLE 24. North America HLA typing for transplant market, by country, 2014 - 2025 (USD Million)
TABLE 25. North America HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 26. North America HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 27. North America HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 28. North America HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 29. North America HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 30. North America HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 31. North America market, by end-use, 2014 - 2025 (USD Million)
TABLE 32. U.S. HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 33. U.S. HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 34. U.S. HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 35. U.S. HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 36. U.S. HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 37. U.S. HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 38. U.S. market, by end-use, 2014 - 2025 (USD Million)
TABLE 39. Canada HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 40. Canada HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 41. Canada HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 42. Canada HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 43. Canada HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 44. Canada HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 45. Canada market, by end-use, 2014 - 2025 (USD Million)
TABLE 46. Europe HLA typing for transplant market, by country, 2014 - 2025 (USD Million)
TABLE 47. Europe HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 48. Europe HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 49. Europe HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 50. Europe HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 51. Europe HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 52. Europe HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 53. Europe market, by end-use, 2014 - 2025 (USD Million)
TABLE 54. Germany HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 55. Germany HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 56. Germany HLA typing for transplant market, by molecular Assays, 2014 - 2025 (USD Million)
TABLE 57. Germany HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 58. Germany HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 59. Germany HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 60. Germany market, by end-use, 2014 - 2025 (USD Million)
TABLE 61. UK HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 62. UK HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 63. UK HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 64. UK HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 65. UK HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 66. UK HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 67. UK market, by end-use, 2014 - 2025 (USD Million)
TABLE 68. France HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 69. France HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 70. France HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 71. France HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 72. France HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 73. France HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 74. France market, by end-use, 2014 - 2025 (USD Million)
TABLE 75. Italy HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 76. Italy HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 77. Italy HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 78. Italy HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 79. Italy HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 80. Italy HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 81. Italy market, by end-use, 2014 - 2025 (USD Million)
TABLE 82. Spain HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 83. Spain HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 84. Spain HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 85. Spain HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 86. Spain HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 87. Spain HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 88. Spain market, by end-use, 2014 - 2025 (USD Million)
TABLE 89. Russia HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 90. Russia HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 91. Russia HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 92. Russia HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 93. Russia HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 94. Russia HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 95. Russia market, by end-use, 2014 - 2025 (USD Million)
TABLE 96. Asia Pacific HLA typing for transplant market, by country, 2014 - 2025 (USD Million)
TABLE 97. Asia Pacific HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 98. Asia Pacific HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 99. Asia Pacific HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 100. Asia Pacific HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 101. Asia Pacific HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 102. Asia Pacific HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 103. Asia Pacific market, by end-use, 2014 - 2025 (USD Million)
TABLE 104. China HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 105. China HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 106. China HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 107. China HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 108. China HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 109. China HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 110. China market, by end-use, 2014 - 2025 (USD Million)
TABLE 111. India HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 112. India HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 113. India HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 114. India HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 115. India HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 116. India HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 117. India market, by end-use, 2014 - 2025 (USD Million)
TABLE 118. Japan HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 119. Japan HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 120. Japan HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 121. Japan HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 122. Japan HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 123. Japan HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 124. Japan market, by end-use, 2014 - 2025 (USD Million)
TABLE 125. Australia HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 126. Australia HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 127. Australia HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 128. Australia HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 129. Australia HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 130. Australia HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 131. Australia market, by end-use, 2014 - 2025 (USD Million)
TABLE 132. Latin America HLA typing for transplant market, by country, 2014 - 2025 (USD Million)
TABLE 133. Latin America HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 134. Latin America HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 135. Latin America HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 136. Latin America HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 137. Latin America HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 138. Latin America HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 139. Latin America market, by end-use, 2014 - 2025 (USD Million)
TABLE 140. Number of transplants performed in Brazil in 2012 and 2014
TABLE 141. Brazil HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 142. Brazil HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 143. Brazil HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 144. Brazil HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 145. Brazil HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 146. Brazil HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 147. Brazil market, by end-use, 2014 - 2025 (USD Million)
TABLE 148. Mexico HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 149. Mexico HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 150. Mexico HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 151. Mexico HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 152. Mexico HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 153. Mexico HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 154. Mexico market, by end-use, 2014 - 2025 (USD Million)
TABLE 155. MEA HLA typing for transplant market, by country, 2014 - 2025 (USD Million)
TABLE 156. MEA HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 157. MEA HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 158. MEA HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 159. MEA HLA typing for transplant market, by sequencing based molecular assays, 2014 - 2025 (USD Million)
TABLE 160. MEA HLA typing for transplant market, by product and services, 2014 - 2025 (USD Million)
TABLE 161. MEA HLA typing for transplant market, by application, 2014 - 2025 (USD Million)
TABLE 162. MEA market, by end-use, 2014 - 2025 (USD Million)
TABLE 163. South Africa HLA typing for transplant market, by technology, 2014 - 2025 (USD Million)
TABLE 164. South Africa HLA typing for transplant market, by non-molecular, 2014 - 2025 (USD Million)
TABLE 165. South Africa HLA typing for transplant market, by molecular assays, 2014 - 2025 (USD Million)
TABLE 166. South Africa HLA typin

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report